Compare DNTH & FULT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNTH | FULT |
|---|---|---|
| Founded | 2015 | 1882 |
| Country | United States | United States |
| Employees | N/A | 3400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.7B |
| IPO Year | 2018 | N/A |
| Metric | DNTH | FULT |
|---|---|---|
| Price | $106.81 | $24.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 4 |
| Target Price | ★ $121.00 | $21.75 |
| AVG Volume (30 Days) | 857.6K | ★ 1.8M |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,036,000.00 | N/A |
| Revenue This Year | N/A | $6.39 |
| Revenue Next Year | $29.48 | $5.52 |
| P/E Ratio | ★ N/A | $10.58 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $18.08 | $16.60 |
| 52 Week High | $112.27 | $25.23 |
| Indicator | DNTH | FULT |
|---|---|---|
| Relative Strength Index (RSI) | 57.71 | 54.19 |
| Support Level | $89.21 | $23.63 |
| Resistance Level | $107.99 | $24.71 |
| Average True Range (ATR) | 6.39 | 0.52 |
| MACD | 0.21 | -0.10 |
| Stochastic Oscillator | 66.23 | 41.55 |
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.